Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL216145 | 0.74 | NOS3 (0.44) | KMT2ATSHR | |
| SCHEMBL6399402 | 0.72 | ALDH1A1 (0.35) | KMT2A | |
| SCHEMBL54818 | 0.71 | CYP11B1 (0.41) | — | |
| SCHEMBL10863167 | 0.70 | NPY5R (0.44) | — | |
| SCHEMBL6402706 | 0.69 | ALDH1A1 (0.35) | KMT2A | |
| SCHEMBL5532575 | 0.69 | ALDH1A1 (0.42) | KMT2A | |
| SCHEMBL20719850 | 0.68 | AR (0.39) | KMT2ATSHR | |
| SCHEMBL1451138 | 0.66 | KMT2A (0.36) | KMT2ATSHR | |
| SCHEMBL21053304 | 0.65 | AR (0.42) | KMT2ATSHR | |
| SCHEMBL1450344 | 0.64 | KCNH2 (0.38) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110033393-A1 | Hydrazone Compounds and Their Use | REDPOINT BIO CORPORATION | 2011-02-10 | — | — | US | disclosed |
| WO-2010132615-A1 | HYDRAZONE COMPOUNDS AND THEIR USE | STEIN PHILIP (US) | 2010-11-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110033393-A1 | Hydrazone Compounds and Their Use | TRPM5, TRPV5, TRPM8 | KMT2A 2304/4885TSHR 1392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.